5-Fluorouracil may enrich cancer stem cells in canine mammary tumor cells in vitro
- Authors:
- Published online on: March 15, 2018 https://doi.org/10.3892/ol.2018.8267
- Pages: 7987-7992
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
Mammary gland carcinomas are the most common neoplasms in women and unsterilized female dogs. Owing to the existence of cancer stem cells (CSCs), chemotherapy is not able to cure these types of diseases completely. A number of studies have demonstrated that CSCs are resistant to chemotherapeutic drugs, but whether canine mammary tumor cells that have acquired resistance to 5‑fluorouracil (5‑FU) exhibited properties of CSCs remains unknown. The aim of the present study was to investigate whether 5‑fluorouracil‑resistant canine mammary tumor cells exhibited properties of CSCs. CSCs were analyzed using western blot assays, ultra‑low attachment sphere cultures, flow cytometry and migration (wound healing and Transwell) assays. The results indicated that, compared with parental cells, proteins associated with the Wnt/β‑catenin signaling pathway and aldehyde dehydrogenase 1 were overexpressed, the number and size of spheres in the 5‑FU‑resistant cells were increased, the ratio of CD44+/CD24‑/low cells was increased and the migratory ability was improved in vitro compared with the 5‑FU‑susceptible cells. In conclusion, stimulation with chemotherapeutic drugs including 5‑FU is a good method for increasing the proportion of canine mammary tumor stem cells in vitro, which may provide further understanding of chemotherapeutic methods and CSCs.